Meyka Pro banner
GeneDx Holdings Corp.

GeneDx Holdings Corp. (WGSWW) Stock Overview

Explore GeneDx Holdings Corp.’s financial performance, market position, analyst ratings, and future outlook.

WGSWWNASDAQ
HealthcareMedical - Healthcare Information Services
$0.00
$0.00(0.00%)
U.S. Market opens in 63h 26m

GeneDx Holdings Corp. (WGSWW)

Meyka AI Score

Z

Key Financials

Market Cap514.5M
P/E Ratio-22.66
EPS (TTM)$-0.04
ROE-0.28%
Fundamental Analysis

AI Price Forecasts

1 Month$0.07
3 Months$0.00
1 Year Target$0.00

WGSWW Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of GeneDx Holdings Corp. (NASDAQ: WGSWW) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, GeneDx Holdings Corp.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of WGSWW on the NASDAQ shows an RSI of 34.46, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind GeneDx Holdings Corp.'s NASDAQ-traded stock include a P/E ratio of -22.66 and a market capitalization of 514.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of WGSWW on the NASDAQ.

Price Performance (NASDAQ: WGSWW)

1-Day Change
N/A
5-Day Change
-97.44%
1-Month Change
-96.77%
3-Month Change
-96.55%
6-Month Change
-99.00%
Year-to-Date (YTD) Change
-99.58%
1-Year Change
-99.63%
3-Year Change
-98.91%
5-Year Change
-99.99%
All-Time (Max) Change
-99.99%

Contact Information

888 729 1206
North Tower, Stamford, CT, 06902

Company Facts

13,000 Employees
IPO DateJul 23, 2021
CountryUS
Actively Trading

Frequently Asked Questions